Pharmacology 101: GLP-1 RAs can increase the sensation of fullness and satiety by activating GLP-1 receptors in the brain
289 , G643G652 (2005)
It has been shown using various atherosclerosis animal models that GLP-1RA therapy is associated with a reduction in atherosclerotic plaques, prevention of aorta intima-media thickening, improvement in vascular endothelial function, reduction of the necrotic zone and an increase of the fibrous component in the plaque and plaque stabilisation
GLP-1 has been reported to act on neural pathways by acting on areas of the brain with a weak blood brain barrier [18,19,20] and vagal afferent [21,22,23]
Para disminuir el apetito e imitar los efectos del medicamento, incluye: al menos 25 gramos de protena, 15 gramos de fibra, menos de 45 gramos de carbohidratos, no ms de 10 gramos de azcar aadida y no ms de 10 gramos de grasa en tu primera comida del da